Charity That Isn't So Charitable

While the FCPA doesn’t mention charitable contributions explicitly, the statute does prohibit giving “anything of value” to a foreign official to induce an official action to obtain or retain business.

Pharmaceutical Companies

David Smyth

November 22, 2016 12:00 AM

Pharmaceutical companies that operate in global markets have to be careful with how their money is spent overseas. That hospital dispensing the company’s products in China? It could be a state-owned enterprise, and at least in the eyes of law enforcement, filled with government officials who could be the recipients of illicit payments. Those travel and entertainment expenses? They might be appropriate, but if too lavish, they could easily cross the line into illegal attempts to curry favor with government buyers. Even contributions to charitable causes can run afoul of the Foreign Corrupt Practices Act (FCPA), and pharmaceutical and medical device companies have fallen into this trap several times.

Here’s the problem: While the FCPA doesn’t mention charitable contributions explicitly, the statute does prohibit giving “anything of value” to a foreign official to induce an official action to obtain or retain business. (15 U.S.C. §§ 78dd-1 – 78dd-3.) And unsurprisingly, the government takes an expansive view of the phrase “anything of value.” A bag of cash is certainly valuable to a lot of people. What about a contribution to a foreign government official’s favorite charity, one that he is particularly invested in?


FCPA practitioners have focused on this issue since 2004, when the SEC brought a settled enforcement action against Schering-Plough arising out of its business in Poland. The SEC’s complaint alleged that one of the company’s foreign subsidiaries, Schering-Plough Poland, made improper payments to the Chudow Castle Foundation, a charitable organization established to restore castles and other historic sites in the Silesian region of Poland. See SEC v. Schering-Plough Corp., No. 04-cv-00945 (D.D.C. June 16, 2004). The foundation was headed by an individual who also happened to be the director of the Silesian Health Fund. The health fund was a Polish governmental body that, among other things, bought pharmaceutical products and influenced the purchase of those products by other entities, including hospitals. The SEC alleged that the subsidiary paid around $76,000 to the Chudow Castle Foundation to induce the director to influence the health fund’s purchase of Schering-Plough’s pharmaceutical products. After allegedly giving Foundation payments false medical justifications, the company was charged with violating the internal controls and books and records provisions of the FCPA, and escaped with a $500,000 penalty.

Eli Lilly

Eli Lilly faced similar issues in 2012, in the same country (Poland), with the same charity (the Chudow Castle Foundation), and the same government agency (the Silesian Health Fund). See SEC v. Eli Lilly and Co., No. 12-cv-02045 (D.D.C. Dec. 20, 2012). To be sure, Eli Lilly also had problems in China, Brazil, and Russia, and its castle issues were mild by comparison. Here, the company paid $39,000 to the Foundation between 2000 and 2003, allegedly in exchange for pharmaceutical business from the health fund. The SEC said that, in its books, Eli Lilly mischaracterized the payments as having true charitable purposes or as compensation for conference space. As it did to Schering-Plough, the SEC charged Eli Lilly with violating the internal controls and books and records provisions of the FCPA.


In 2013, Michigan-based medical technology company Stryker Corporation found itself the subject of a wide-ranging SEC administrative order focused on its alleged FCPA violations. While the company’s problems spanned three continents, it was in Greece that it stumbled into the charitable contribution trap. According to the SEC’s order, Stryker’s subsidiary in Greece made a purported “donation” of nearly $200,000 in 2007 to a public university in Greece to fund a laboratory that was a pet project of a public hospital doctor. In re Stryker Corp., Admin. Proc. File No. 3-15587 (Oct. 24, 2013). In exchange for the payment, the doctor agreed to provide business to Stryker. Again, the SEC’s order alleged violations of the FCPA’s internal controls and books and records provisions.

What to do

These cases offer lessons about how to assess charitable contributions in countries where pharmaceutical companies do business. Companies should certainly ask themselves these questions:

◾ Does the company have internal guidance regarding its charitable activity? For example, does the company confine that activity to a certain sector, such as health-related causes?
◾ Does the proposed contribution fit within that guidance?
◾ How large is the proposed contribution compared to the company’s overall charity budget?
◾ Do repeated charitable contributions within a short time appear to be structured to avoid going over established authorization limits?
◾ Do government agencies and charitable foundations share common personnel?
◾ How are donations characterized in corporate books? Do those descriptions make sense?

Asking these questions and rigorously demanding answers will put companies on strong footing for FCPA compliance. Companies should also train accounting staff to recognize red flags when they arise.

Good arguments can be made that the FCPA should not even cover the payments described in the cases described above. Unfortunately, winning those arguments can be prohibitively expensive. Empowering personnel to recognizing these issues before they become problematic can save enormous sums in the long run.

For more information, follow the source link below.

Related Articles

This German Firm Protects Their Clients in the Face of Emerging Technologies

by Best Lawyers

Johannes Heselberger discusses theft of trade secrets, the pharmaceutical industry, and fake goods.

An Interview With Bardehle Pagenberg

Fighting for Justice

by Best Lawyers

How They Have Fought for Clients Every Step of the Way

Fighting for Justice

Trending Articles

The Best Lawyers in Spain™ 2023

by Best Lawyers

Announcing Spain's recognized lawyers for 2023.

Flag of Spain

Announcing the 2023 The Best Lawyers in America Honorees

by Best Lawyers

Only the top 5.3% of all practicing lawyers in the U.S. were selected by their peers for inclusion in the 29th edition of The Best Lawyers in America®.

Gold strings and dots connecting to form US map

The Best Lawyers in Chile™ 2023

by Best Lawyers

The results include an elite field of top lawyers and firms in Chile.

White star in blue box beside white box with red box on bottom

The Best Lawyers in South Africa™ 2023

by Best Lawyers

Best Lawyers proudly announces lawyers recognized in South Africa for 2023.

South African flag

The 2023 Best Lawyers in Portugal™

by Best Lawyers

Announcing the elite group of lawyers recognized in Portugal for 2023.

Green and red Portuguese flag

Announcing The Best Lawyers in Peru™ 2023

by Best Lawyers

Honoring our awarded lawyers for 2023 in Peru.

Red and white stripes with green leaf symbol

The Best Lawyers in Spain™ 2022

by Best Lawyers

The results include an elite field of top lawyers and firms.

The Best Lawyers in Spain™ 2022

Best Lawyers: Ones to Watch in America for 2023

by Best Lawyers

The third edition of Best Lawyers: Ones to Watch in America™ highlights the legal talent of lawyers who have been in practice less than 10 years.

Three arrows made of lines and dots on blue background

Thirteen Years of Excellence

by Best Lawyers

For the 13th consecutive year, “Best Law Firms” has awarded the most elite and talented law firms across the country through a thorough and trusted data review process.

Red, white and blue pipes and writing on black background

Famous Songs Unprotected by Copyright Could Mean Royalties for Some

by Michael B. Fein

A guide to navigating copyright claims on famous songs.

Can I Sing "Happy Birthday" in Public?


Rewriting 𝙃𝙀𝙍𝙨𝙩𝙤𝙧𝙮 One Verdict at a Time

by Justin Smulison

Athea Trial Lawyers was formed only a year ago by several prestigious lawyers seeking justice for their clients, and together they are making history.

Six female lawyers sitting in office

Announcing the 2022 Best Lawyers® in the United States

by Best Lawyers

The results include an elite field of top lawyers listed in the 28th Edition of The Best Lawyers in America® and in the 2nd Edition of Best Lawyers: Ones to Watch in America for 2022.

2022 Best Lawyers Listings for United States

Announcing the 2023 The Best Lawyers in Canada Honorees

by Best Lawyers

The Best Lawyers in Canada™ is entering its 17th edition for 2023. We highlight the elite lawyers awarded this year.

Red map of Canada with white lines and dots

What the Courts Say About Recording in the Classroom

by Christina Henagen Peer and Peter Zawadski

Students and parents are increasingly asking to use audio devices to record what's being said in the classroom. But is it legal? A recent ruling offer gives the answer to a question confusing parents and administrators alike.

Is It Legal for Students to Record Teachers?

Strength in Numbers: When Partnering Up May Be Best in Whistleblower Litigation

by Justin Smulison

Whistleblower claims make headlines when they result in multimillion-dollar settlements. But the journey to the courtroom is characterized by complexity and requires time and resources. Bienert Katzman Littrell Williams partner and The Best Lawyers in America awardee Michael R. Williams discusses when and why partnerships between counsel will strengthen whistleblower litigation.

A Blue Person in the Middle of White People

Announcing the 2022 "Best Law Firms" Rankings

by Best Lawyers

The 2022 “Best Law Firms” publication includes all “Law Firm of the Year” recipients, national and metro Tier 1 ranked firms and editorial from thought leaders in the legal industry.

The 2022 Best Law Firms Awards